ELI LILLY & Co — Director's Dealing 2021

Jun 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2021-06-01

Reporting Person: Rau Diogo (SVP & CIDO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-01	Restricted Stock Unit	$	A	20160	Acquired		Common Stock (20160.0)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

F2: The restricted stock units vest in three installments, 7,560 on June 1, 2022, 6,300 on June 1, 2023, and 6,300 on June 1, 2024.